SE8803566L - Rekombinantisk, maenniskointerleukin-2-syntesen kodande plasmid-dna av ppr-il2-19-typ, foerfarande foer konstruering av denna plasmid-dna och maenniskointerleukin-2-producerande, naemnda plasmid-dna innehaallande bakteriestam av kulturen escherichia coli vniigenetika vl 903 (ppr-il2-19) - Google Patents

Rekombinantisk, maenniskointerleukin-2-syntesen kodande plasmid-dna av ppr-il2-19-typ, foerfarande foer konstruering av denna plasmid-dna och maenniskointerleukin-2-producerande, naemnda plasmid-dna innehaallande bakteriestam av kulturen escherichia coli vniigenetika vl 903 (ppr-il2-19)

Info

Publication number
SE8803566L
SE8803566L SE8803566A SE8803566A SE8803566L SE 8803566 L SE8803566 L SE 8803566L SE 8803566 A SE8803566 A SE 8803566A SE 8803566 A SE8803566 A SE 8803566A SE 8803566 L SE8803566 L SE 8803566L
Authority
SE
Sweden
Prior art keywords
plasmid
ppr
plasmid dna
maenniscointerleukin
paa1213
Prior art date
Application number
SE8803566A
Other languages
English (en)
Swedish (sv)
Other versions
SE8803566D0 (sv
Inventor
V G Debabov
E Y Gren
J I Kozlov
S V Mashko
A Y Strongin
V E Sterkin
V L Jurin
S V Kostrov
A J Tsimanis
Original Assignee
Inst Organicheskogo Sinteza Ak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Organicheskogo Sinteza Ak filed Critical Inst Organicheskogo Sinteza Ak
Publication of SE8803566D0 publication Critical patent/SE8803566D0/xx
Publication of SE8803566L publication Critical patent/SE8803566L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8803566A 1987-02-09 1988-10-07 Rekombinantisk, maenniskointerleukin-2-syntesen kodande plasmid-dna av ppr-il2-19-typ, foerfarande foer konstruering av denna plasmid-dna och maenniskointerleukin-2-producerande, naemnda plasmid-dna innehaallande bakteriestam av kulturen escherichia coli vniigenetika vl 903 (ppr-il2-19) SE8803566L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU874191353A SU1703693A1 (ru) 1987-02-09 1987-02-09 Рекомбинантна плазмидна ДНК @ - @ 2-19, кодирующа синтез интерлейкина-2 человека, способ ее конструировани @ штамм бактерий ЕSснеRIснIа coLI - продуцент интерлейкина-2 человека

Publications (2)

Publication Number Publication Date
SE8803566D0 SE8803566D0 (sv) 1988-10-07
SE8803566L true SE8803566L (sv) 1988-10-07

Family

ID=21284358

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8803566A SE8803566L (sv) 1987-02-09 1988-10-07 Rekombinantisk, maenniskointerleukin-2-syntesen kodande plasmid-dna av ppr-il2-19-typ, foerfarande foer konstruering av denna plasmid-dna och maenniskointerleukin-2-producerande, naemnda plasmid-dna innehaallande bakteriestam av kulturen escherichia coli vniigenetika vl 903 (ppr-il2-19)

Country Status (10)

Country Link
JP (1) JPH01502639A ( )
CH (1) CH676997A5 ( )
DE (1) DE3890052T1 ( )
FI (1) FI884557A0 ( )
GB (1) GB2210373A ( )
HU (1) HUT50873A ( )
NL (1) NL8820102A ( )
SE (1) SE8803566L ( )
SU (1) SU1703693A1 ( )
WO (1) WO1988005818A1 ( )

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58116498A (ja) * 1981-12-28 1983-07-11 Takeda Chem Ind Ltd Ｉｌ‐２をコードする新規伝令ｒｎａの製造法
JPH0646957B2 (ja) * 1985-03-11 1994-06-22 武田薬品工業株式会社 インタ−ロイキン−２の製造方法
WO1986006410A1 (en) * 1985-04-30 1986-11-06 Takeda Chemical Industries, Ltd. Process for increasing yield of interleukin-2

Also Published As

Publication number Publication date
SE8803566D0 (sv) 1988-10-07
CH676997A5 ( ) 1991-03-28
FI884557A (fi) 1988-10-04
GB8823729D0 (en) 1988-12-07
WO1988005818A1 (en) 1988-08-11
HUT50873A (en) 1990-03-28
FI884557A0 (fi) 1988-10-04
NL8820102A (nl) 1989-01-02
SU1703693A1 (ru) 1992-01-07
GB2210373A (en) 1989-06-07
DE3890052T1 (de) 1989-04-13
JPH01502639A (ja) 1989-09-14

Similar Documents

Publication Publication Date Title
Friedman et al. Evidence that ribosomal protein S10 participates in control of transcription termination.
EP0088195A3 (en) Messenger rna, production and use thereof
Kaiser et al. Gene transfer to myxobacterium by Escherichia coli phage P1
Konrad et al. Novel mutants of Escherichia coli that accumulate very small DNA replicative intermediates.
EP0732404A1 (en) Novel expression screening vector
FI820075L (fi) Rekombination-dna-medel och foerfarande
EP0103395A3 (en) Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield
PT84801A (en) Secretory signal selection vectors for extracellular protein synthesis in bacilli
IL91705A0 (en) Interleukin-4 receptors,dna and expression vectors encoding them and process for producing the receptors
JPS55131397A (en) Preparation of l-threonine by fermentation
CN1045539C (zh) 克隆编码具有人粒性巨噬细胞和嗜伊红细胞生长因子活性多肽的cDNA
Mindell et al. Structure/function analysis of the transmembrane domain of DAB389-interleukin-2, an interleukin-2 receptor-targeted fusion toxin. The amphipathic helical region of the transmembrane domain is essential for the efficient delivery of the catalytic domain to the cytosol of target cells
SE8502162D0 (sv) Framstellning av protein g och/eller fragment derav
Macrina et al. R6K plasmid replication: influence of chromosomal genotype in minicell-producing strains of Escherichia coli K-12
Tsukagoshi et al. Molecular cloning of a major cell wall protein gene from protein-producing Bacillus brevis 47 and its expression in Escherichia coli and Bacillus subtilis
ES8300857A1 (es) Un procedimiento para la sintesis de insulina humana
TWI751154B (zh) 一種重組人粒細胞集落刺激因子的製備方法
SE8803566L (sv) Rekombinantisk, maenniskointerleukin-2-syntesen kodande plasmid-dna av ppr-il2-19-typ, foerfarande foer konstruering av denna plasmid-dna och maenniskointerleukin-2-producerande, naemnda plasmid-dna innehaallande bakteriestam av kulturen escherichia coli vniigenetika vl 903 (ppr-il2-19)
HU194316B (en) Process for preparing alpha-l human leukocyte interferone
JPS61500586A (ja) インタ−ロイキン−２産生のための方法及び組成物
CN101988049B (zh) 共表达小鼠膜型白细胞介素15和Rae-1ε的转基因细胞及其制备方法
CN1034427C (zh) 用载体转化骨髓瘤细胞生产肽的方法
DE3687112D1 (de) Verfahren zur ausscheidung von genprodukten in das wachstumsmedium von gram-negativen bakterien.
CN1244696C (zh) 白细胞介素－12的高效表达方法
SE8803567D0 (sv) Rekombinantisk, syntesen av maenniskofibroblast-beta1-interferon kodande plasmid-dnappr-ifnbeta-13, foerfarande foer konstruering av naemnda plasmid-dna och maennisko-beta1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika vl 903 (ppr-ifnbeta-13)

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8803566-2

Effective date: 19920901